These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10153971)

  • 1. Investors explore buying technology data.
    Morrissey J
    Mod Healthc; 1996 Jan; 26(3):19. PubMed ID: 10153971
    [No Abstract]   [Full Text] [Related]  

  • 2. The new world disorder.
    Stires D
    Fortune; 2002 Dec; 146(12):62-4, 68, 70 passim. PubMed ID: 12500480
    [No Abstract]   [Full Text] [Related]  

  • 3. Rx for investors.
    Stires D
    Fortune; 2004 May; 149(9):158-60, 162, 164 passim. PubMed ID: 15124332
    [No Abstract]   [Full Text] [Related]  

  • 4. Eli Lilly enters venture capital arena.
    Fletcher L
    Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
    [No Abstract]   [Full Text] [Related]  

  • 5. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China moves to help high-tech firms.
    Cyranoski D
    Nature; 2009 Nov; 462(7270):149. PubMed ID: 19907464
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug firms' woes may slow profit growth.
    Dine DD
    Mod Healthc; 1989 Feb; 19(7):52. PubMed ID: 10291927
    [No Abstract]   [Full Text] [Related]  

  • 8. As Genzyme flounders, competitors and activist investors swoop in.
    Allison M
    Nat Biotechnol; 2010 Jan; 28(1):3-4. PubMed ID: 20062016
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustaining agbiotechnology through lean times.
    McElroy D
    Nat Biotechnol; 2003 Sep; 21(9):996-1002. PubMed ID: 12949560
    [No Abstract]   [Full Text] [Related]  

  • 11. Sense and antisense for investors.
    Jacobs T
    Nat Biotechnol; 2002 Jun; 20(6):543. PubMed ID: 12042846
    [No Abstract]   [Full Text] [Related]  

  • 12. Investors likely to venture back as crisis subsides.
    Glick JL
    Nature; 2009 Aug; 460(7259):1079. PubMed ID: 19713912
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiating genomics companies.
    James R
    Nat Biotechnol; 2000 Feb; 18(2):153-5. PubMed ID: 10657119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centacor stock dips again after articles on Centoxin.
    Wagner M
    Mod Healthc; 1992 Apr; 22(17):20. PubMed ID: 10117574
    [No Abstract]   [Full Text] [Related]  

  • 15. How the street sees biotech.
    Lashinsky A
    Fortune; 2003 Jun; 147(11):86. PubMed ID: 12800576
    [No Abstract]   [Full Text] [Related]  

  • 16. Health purveyors that look hale.
    McFadden M
    Fortune; 1986 May; 113(11):147-8, 150. PubMed ID: 10276676
    [No Abstract]   [Full Text] [Related]  

  • 17. AHP's awful losing streak.
    Whitford D
    Fortune; 1999 Nov; 140(10):52, 56. PubMed ID: 10662389
    [No Abstract]   [Full Text] [Related]  

  • 18. Spinning the wheel on ImClone.
    Varchaver N
    Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
    [No Abstract]   [Full Text] [Related]  

  • 19. The perfect mix for your portfolio.
    Simons J
    Fortune; 2003 Dec; 148(13):134-8. PubMed ID: 14712541
    [No Abstract]   [Full Text] [Related]  

  • 20. Antivirals--an increasingly healthy investment.
    McCarthy B
    Nat Biotechnol; 2007 Dec; 25(12):1390-3. PubMed ID: 18066033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.